Researchers found little risk for secondary cancers from multi-detector computed tomography among the Medicare population.
Despite increasing radiation doses and reliance on CT scans in diagnosis and treatment, the risk for secondary cancers is low among older adults, according to a study published in the April issue of the Journal of the American College of Radiology.
Evidence shows that use of multi-detector CT scans (MDCT) provide better diagnosis and disease management, but there has been concern that the increased use may cause secondary cancers from the radiation, particularly among older patients who most frequently undergo the scanning.
Researchers from Stanford University in Stanford, Calif. undertook a retrospective cohort study using Medicare claims spanning eight years. Using two cohorts (1998 to 2001 and 2002 to 2005), the researchers found that although scans of the head were the most common, abdominal imaging delivered the greatest proportion of radiation (43 percent in the first cohort, and 40 percent in the second).
In the first cohort, 42 percent of patients underwent CT scans, with 2.2 percent and 0.5 percent receiving radiation doses in the low and high ranges, respectively. In the second cohort, 50 percent of patients received CT scans, with 4.2 percent and 1.2 percent receiving doses in the low and high ranges.
“Combining both low-risk and high-risk patient groups (50-100 and >100 mSv), as well as those who received <50 mSv, we estimate that 1,659 cases of cancer (0.03 percent of the study population) will develop in the 1998 to 2001 cohort and 2,185 (0.04 percent of the study population) in the 2002 to 2005 cohort,” according to Aabed Meer, AB, author of the study.
The continued rise of such imaging use and radiation exposure call for more research to limit ill effects, researchers said.
“Although modern CT imaging is a vital part of medical care, its utilization must include a conscious acknowledgment of radiation exposure and an awareness of the pursuant carcinogenic risk. As medical care continues its dependence on advance technologies, such as MDCT, we emphasize the importance of continuing research that encourages the exploration of lower radiation dose technologies,” Meer concluded.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.